FDA inspection
Takeda Manufacturing Singapore Pte. Ltd.: FDA inspection ending Nov 18, 2022
FDA inspection 1192281 · Voluntary Action Indicated (VAI) · Singapore
Key facts
| Inspection ID | 1192281 |
|---|---|
| Firm | Takeda Manufacturing Singapore Pte. Ltd. |
| FEI number | 3009153654 |
| Address | 2a Woodlands Industrial Park D |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2023 |
| Inspection end date | Nov 18, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data